AVITA Medical (AVH) Fundamentals 2026 — Revenue Analysis | SniperIQ
AVITA Medical (AVH) is a US-listed Healthcare company in Medical - Devices with a market capitalization of A
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is AVITA Medical's market cap?
AVITA Medical (AVH) has a market capitalization of approximately A
How profitable is AVITA Medical?
AVITA Medical runs a net profit margin of -62.7%, a gross margin of 81.4%, and an operating margin of -54.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does AVITA Medical generate?
AVITA Medical reported revenue of $74M for fiscal year 2025, with net income of -$50M and earnings per share (EPS) of -0.36. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does AVITA Medical pay a dividend?
AVITA Medical does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is AVITA Medical financially healthy?
AVITA Medical carries a debt-to-equity ratio of -2.08x and a current ratio of 0.47x, with a market beta of 1.86. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is AVITA Medical a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For AVITA Medical (AVH) the key facts are: market cap A
Track AVITA Medical's full fundamentals live
Get AVITA Medical's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.